Targeted Commercialization
Targeted Commercialization is an insight-led, expert-built precision commercialization model that reshapes how therapies reach market. Built for today’s therapies and tomorrow’s ambitions, Targeted Commercialization adapts to your exact needs, whether launching broad diagnostic-enabled therapies or highly targeted rare disease treatments. It's lean, agile, and deeply personalized - aligning strategy, people, data, and actions at the right moment in time.
Targeted Commercialization empowers you to truly understand the market landscape, shape a launch strategy that fits your therapy, and execute it collaboratively with a partner who’s invested in your success.
Precision therapies deserve precision commercialization
Targeted Commercialization is a new model for commercializing precision medicine. Strategic, data-powered, and agile by design
It’s not extra. It’s essential
Source: Data insights sourced from Diaceutics’ client projects.
We Fix Testing
Together with our Lab Network, unique testing data insights, digital and personal engagement solutions, we can understand and address testing inefficiencies.
We Find Patients
Our data-first approach enables us to find patients at precisely the right time to positively impact testing and treatment decisions.
We Engage Physicians
With tailored messaging based on their behaviour via digital and expert outreach. We can reach physicians with just-in-time digital and personal educational messages within 24 hours of a testing event.
Precision commercialization for precision therapies
Traditional commercialization models are misaligned with the needs of precision medicine.
Targeted Commercialization is purpose-built to address the needs of precision therapies. Focusing on testing optimization, biomarker education and treatment adoption driven by data, expertise and an integrated suite of engagement tools.
Strategic partnership, not a vendor
Just as targeted therapies are designed to meet a patient’s unique needs, we collaborate with you to craft commercialization strategies precisely tailored to your therapy’s requirements.
We work as an extension of your team, navigating a complex landscape together with precision and insight. This isn’t outsourcing - it’s a strategic partnership grounded in shared goals, seamless integration, and an unwavering commitment to long-term success.
Agile by design at every stage of commercialization
Unlike traditional commercialization models that rely on templated strategies and expansive field teams, our agile approach leverages real-time data to zero in on high-impact activities and dynamically realign tactics for optimal results.
Resources
Unlike traditional commercialization, Targeted Commercialization is a precision-first model that integrates industry expertise, real-time data with Lab and HCP engagement to co-create and execute tailored launch strategies for precision medicines.
Discover more about Targeted Commercialization by clicking into the resources below:
Webinar
Rethinking drug commercialization: navigating a shifting biotech investment landscape
Delivering a deep dive into today’s biotech investment climate and practical strategies to navigate commercialization when pharma partnerships are delayed or uncertain.
Webinar
Navigating precision commercialization: partnering for success in rare & precision therapies
Discover how Diaceutics’ Targeted Commercialization model empowers biopharma to launch smarter, leaner strategies for targeted therapies through real-world insights and partnership.